Our client was seeking market authorisation for one indication and were expected a secondary indicat...
Read moreOur client had in-licenced a hospital drug that they were seeking to launch in the EU, following a r...
Read moreOur client was struggling to understand the value of their product (a single-use treatment for an ul...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read moreWebinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreOur experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...
Read moreIntroduction Real World Data is being increasingly used across the globe to support medical-product ...
Read moreOur experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...
Read moreNICE guidance published today on digital health technologies suggest they can be used to help young ...
Read more